M&A Advisors in San Luis Obispo

Background: We are an M&A advisory firm based in Tel Aviv, Israel. We specialize in business consulting and advisory services to clients in Israel. We cater to healthcare and industrial businesses. We charge both an upfront fee and a success fee.

Background: Boutique investment bank based in Oslo, Norway. Licensed by the UK Financial Conduct Authority. Expertise in M&A transactions and company restructuring. On the platform, I am looking to be an advisory or investment opportunities.

Background: A subsidiary of an enterprise founded in 1993 and headquartered in Beijing, we are a leading investment, operation, and management group in China, with a presence in over 50 countries globally and annual sales of approximately RMB200 bn (c. US$30.8 bn1). • The pharmaceutical and healthcare business represents a core. Focus area for the group and comprises 40+ companies with total sales of. RMB38 bn (US$5.8 bn) in 2017. • On a consolidated basis, we ranked among the top 5 manufacturers by sales in the Chinese pharmaceutical market in 2017. • We have established four major industrial platforms: (i) Generic pharma; (ii) Specialty pharma; (iii) Traditional Chinese Medicine (TCM); and (iv) bio-pharmaceuticals. Our focus is a cross-border and domestic license (license-in, including both clinical stage and commercial-stage products), tech transfer, acquisition, distribution, and co-development of live biotherapeutic products, and investment in novel microbiome Research platforms.

Background: A subsidiary of an enterprise founded in 1993 and headquartered in Beijing, we are a leading investment, operation, and management group in China, with a presence in over 50 countries globally and annual sales of approximately RMB200 bn (c. US$30.8 bn1). • The pharmaceutical and healthcare business represents a core. Focus area for the group and comprises 40+ companies with total sales of. RMB38 bn (US$5.8 bn) in 2017. • On a consolidated basis, we ranked among the top 5 manufacturers by sales in the Chinese pharmaceutical market in 2017. • We have established four major industrial platforms: (i) Generic pharma; (ii) Specialty pharma; (iii) Traditional Chinese Medicine (TCM); and (iv) bio-pharmaceuticals. Our focus is a cross-border and domestic license (license-in, including both clinical stage and commercial-stage products), tech transfer, acquisition, distribution, and co-development of live biotherapeutic products, and investment in novel microbiome Research platforms.

Background: We provide advisory services in the M&A segment to our clients. We do not charge an upfront fee. We do charge a success fee. Our clients are interested in business opportunities in North America, Europe and Germany as it is convenient for them to collaborate with businesses in these countries.

Background: Primary Industries: Financial Technology (Fintech) Cryptocurrency & Digital Assets. Payment Services. Gaming & Gambling. Asset Management & Funds. Corporate Services. Regulatory Compliance. Specific Service Areas: Trust and Company Services. Corporate Structuring & Formation. Regulatory Licensing & Authorization. Financial Services Licensing. Money Services Business (MSB) Formation. Crypto Asset Service Provider (CASP) Licensing. MiCA Compliance & Authorization. Electronic Money Institution (EMI) Licensing. Payment Institution (PI) Licensing. Alternative Investment Fund Management (AIFM) Small Fund Structuring. Online Gaming & Gambling Licensing. Virtual Casino Licensing. EU Company Formation. Cross-border Corporate Structuring. Banking Integration & Payment Solutions. Compliance Frameworks (AML/KYC/CTF) Financial Advisory Services. Mergers & Acquisitions (M&A) Advisory. Corporate Finance Advisory. Due Diligence Services. Corporate Restructuring. International Tax Planning. Regulatory Strategy Consulting. Geographic Focus: European Union (Estonia-based operations) Canada (MSB & Financial Services) Cross-border/Multi-jurisdictional structures. Target Clients: Fintech founders & startups. Crypto entrepreneurs. International businesses. Investment fund managers. Gaming operators. Payment service providers.

Background: Great product but needs financing or sales channels to scale.